3785
|
ABT-639
|
Peripherally acting, selective and orally bioavailable T-type Ca2+ channel blocker |
€115.00 |
3742
|
Apararenone
|
Potent and highly selective nonsteroidal mineralocorticoid receptor (MR) antagonist |
€130.00 |
3771
|
AZD2858
|
Potent and highly selective Glycogen Synthase Kinase-3β inhibitor |
€95.00 |
3808
|
AZD3458
|
Orally bioavailable potent and selective PI3Kγ inhibitor |
Inquire |
3800
|
AZD4573
|
Inhibitor of CDK9 |
Inquire |
3778
|
BAY-091
|
First potent and highly selective PIP4K2A inhibitor |
€130.00 |
3638
|
BAY-179
|
Potent, selective, and species cross-reactive complex I inhibitor |
€100.00 |
3786
|
BP-1-102
|
Orally bioavailable STAT3 inhibitor |
€90.00 |
3613
|
EN219
|
Covalent RNF114 ligand |
€120.00 |
3787
|
Grapiprant
|
Potent, selective, competitive and orally bioavailable prostaglandin EP4 receptor antagonist |
€100.00 |
3807
|
GS-9901
|
Potent and isoform-selective inhibitor of PI3Kδ |
Inquire |
3791
|
LCS3
|
Reversible and uncompetitive inhibitor of GSR and TXNRD1 |
€90.00 |
3805
|
MK-3697
|
Potent and selective Orexin receptor antagonist |
Inquire |
3796
|
MRTX1719 hydrochloride
|
Inhibitor of the PRMT5.MTA complex |
Inquire |
3798
|
PF-06855800
|
SAM-pocket-binding (SAM competitive) PRMT5 inhibitor |
Inquire |
3746
|
PTI-125 dihydrochloride
|
Orally available molecule targeting filamin A (FLNA) |
€120.00 |
3803
|
SCH900353
|
ERK1/2 inhibitor |
Inquire |
3797
|
TAK-981 oxalate
|
Inhibitor of SUMOylation |
€110.00 |
3802
|
TAS6417
|
EGFR inhibitor |
Inquire |
3794
|
Urolithin A
|
Inhibitor of the PI3K/AKT/mTOR pathway |
€70.00 |
3801
|
Voruciclib
|
Inhibitor of CDK9 |
Inquire |
3789
|
YH-306
|
FAK inhibitor |
€90.00 |
3790
|
ZINC69391
|
Specific Rac1 inhibitor |
€110.00 |